Clinical Trial

BFR Training for Post ACLR

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 27, 2025 (before its estimated November 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
This randomized clinical trial is designed to compare three different rehabilitation methods for patients who have undergone anterior cruciate ligament (ACL) reconstruction. The study aims to determine whether low-load blood flow restriction training (LL-BFRt) is more effective than high-load eccentric training (HL-Et) and a sham LL-BFRt in improving three key areas: patellar position, muscle morphology, and leg function. Study Design and Interventions Participants will be randomly assigned to one of the three intervention groups. All groups will perform eccentric exercises, including single leg squats, single leg deadlifts, lateral step downs, and single leg calf raises. The key differences lie in the load and the use of blood flow restriction: LL-BFRt Group: Participants will train at 30% of their repetition maximum (RM) while a cuff restricts blood flow to 70% of their artery occlusion pressure (AOP). HL-Et Group: Participants will train at a higher intensity, using 70% of their repetition maximum (RM), with no blood flow restriction. Sham LL-BFRt Group: Participants will perform the same exercises as the LL-BFRt group at 30% of their RM, but the cuff will not be inflated to a pressure that restricts blood flow. After the training period, the researchers will compare the outcomes across all three groups to see which method leads to the most significant improvements in patella position, muscle morphology, and leg function.
Trial Details
NCT Number NCT07142889
Lead Sponsor Udayana University
Conditions Blood Flow Restriction Training, Patella Position, Muscle Morphology, Anterior Cruciate Ligament Reconstruction, Leg Function
Enrollment 60 participants
Start Date 2025-09-01
Primary Completion 2025-11-20 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-27